NRSN
Price
$1.18
Change
+$0.01 (+0.85%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
29.3M
70 days until earnings call
SLRX
Price
$5.55
Change
-$0.14 (-2.46%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
2.9M
Interact to see
Advertisement

NRSN vs SLRX

Header iconNRSN vs SLRX Comparison
Open Charts NRSN vs SLRXBanner chart's image
NeuroSense Therapeutics
Price$1.18
Change+$0.01 (+0.85%)
Volume$1.99K
Capitalization29.3M
Salarius Pharmaceuticals
Price$5.55
Change-$0.14 (-2.46%)
Volume$100
Capitalization2.9M
NRSN vs SLRX Comparison Chart in %
Loading...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRSN vs. SLRX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRSN is a Hold and SLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (NRSN: $1.17 vs. SLRX: $5.69)
Brand notoriety: NRSN and SLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRSN: 27% vs. SLRX: 84%
Market capitalization -- NRSN: $29.3M vs. SLRX: $2.78M
NRSN [@Biotechnology] is valued at $29.3M. SLRX’s [@Biotechnology] market capitalization is $2.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRSN’s FA Score shows that 0 FA rating(s) are green whileSLRX’s FA Score has 0 green FA rating(s).

  • NRSN’s FA Score: 0 green, 5 red.
  • SLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, NRSN is a better buy in the long-term than SLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRSN’s TA Score shows that 5 TA indicator(s) are bullish while SLRX’s TA Score has 5 bullish TA indicator(s).

  • NRSN’s TA Score: 5 bullish, 3 bearish.
  • SLRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both NRSN and SLRX are a good buy in the short-term.

Price Growth

NRSN (@Biotechnology) experienced а 0.00% price change this week, while SLRX (@Biotechnology) price change was +22.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was +5.87%, and the average quarterly price growth was +34.62%.

Reported Earning Dates

NRSN is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRSN($29.3M) has a higher market cap than SLRX($2.9M). NRSN YTD gains are higher at: -1.667 vs. SLRX (-79.891). SLRX has higher annual earnings (EBITDA): -5.18M vs. NRSN (-8.55M). SLRX has more cash in the bank: 795K vs. NRSN (666K). NRSN has less debt than SLRX: NRSN (19K) vs SLRX (112K). NRSN (0) and SLRX (0) have equivalent revenues.
NRSNSLRXNRSN / SLRX
Capitalization29.3M2.9M1,010%
EBITDA-8.55M-5.18M165%
Gain YTD-1.667-79.8912%
P/E RatioN/AN/A-
Revenue00-
Total Cash666K795K84%
Total Debt19K112K17%
FUNDAMENTALS RATINGS
SLRX: Fundamental Ratings
SLRX
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRSNSLRX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCOR72.560.84
+1.17%
Procore Technologies
ACHC21.920.21
+0.97%
Acadia Healthcare Company
CMCO14.80-0.04
-0.24%
Columbus McKinnon Corp
UPLD2.43-0.05
-2.02%
Upland Software
AIHS2.59-0.08
-3.00%
Senmiao Technology Limited

NRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRSN has been loosely correlated with NEVPF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NRSN jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+0.85%
NEVPF - NRSN
49%
Loosely correlated
N/A
PBM - NRSN
38%
Loosely correlated
-1.32%
SLRX - NRSN
32%
Poorly correlated
-2.46%
CTMX - NRSN
31%
Poorly correlated
-1.28%
DNLI - NRSN
29%
Poorly correlated
-1.51%
More

SLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRX has been closely correlated with MBIO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if SLRX jumps, then MBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRX
1D Price
Change %
SLRX100%
-2.46%
MBIO - SLRX
71%
Closely correlated
+3.80%
PHIO - SLRX
40%
Loosely correlated
-2.31%
AZTR - SLRX
35%
Loosely correlated
-2.60%
NRSN - SLRX
32%
Poorly correlated
+0.85%
KNSA - SLRX
29%
Poorly correlated
-0.95%
More